Tarlatumab (Clinical Trials and Research) The development of Tarlatumab has been supported by several clinical trials. These studies have aimed to evaluate the safety, efficacy, and tolerability of the drug in patients with IPF. Reduction in lung function decline: Tarlatumab has shown the potential to slow down the progression of IPF, as measured by lung […]
Category: Oncology
Tarlatamab (Mechanism of Action) Tarlatamab is an innovative anticancer drug that was recently approved for treating extensive-stage small cell lung cancer (ES-SCLC). It represents a significant advancement in cancer therapy as the first bispecific T-cell engager (BiTE) approved for a solid tumor. Mechanism of Action Tarlatamab works by engaging the body’s immune system to target […]
Categories
Tepotinib (Indications)
Tepotinib (Indications) Non-Small Cell Lung Cancer (NSCLC): Specifically approved for patients with metastatic NSCLC who have MET exon 14 skipping mutations. This genetic alteration is present in a small subset of NSCLC patients and is associated with poor prognosis.
Categories
Tepotinib (Mechanism of Action)
Tepotinib (Mechanism of Action) Tepotinib is a targeted therapy drug approved for the treatment of metastatic non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations. Here are key details about tepotinib: Mechanism of Action MET Inhibitor: Tepotinib is a selective inhibitor of the MET receptor tyrosine kinase. Mutations or alterations in the MET […]
Categories
Mefenamic Acid (Uses)
Mefenamic Acid (Uses) Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain, including menstrual pain. It works by reducing inflammation and blocking the production of certain natural substances in the body that cause pain and inflammation. Here are some key points about mefenamic acid: Uses: Pain relief: Commonly used […]
Pericardial Mesothelioma (Research-1) Here is an overview of the latest research and developments in understanding and treating pericardial mesothelioma: Diagnosis Diagnosing pericardial mesothelioma is challenging due to its rarity and non-specific symptoms, which often resemble other cardiac conditions. Advances in diagnostic techniques include: Imaging Tests: Echocardiograms, CT scans, and MRI are used to detect abnormalities […]